Risk Minimisation Materials

Cover Letter – Risk Minimisation Materials

This letter outlines the risk minimisation materials developed to explain the corneal adverse reactions that may occur with belantamab mafodotin treatment and to provide monitoring and management guidance.

For Healthcare Professionals